Summary
- Current Price
- As of today, EGRX price is $0.97, unchanged in the most recent trading session on
- Current Price All-Time High
- EGRX price is currently -99.07% below its historical high of $104.17 set on
- Market Cap
- EGRX current market cap is $13M, down -67.51% year-over-year
- PE Ratio
- EGRX current PE ratio is 1.07
- Revenue
- EGRX current annual revenue is $316.61M, up +84.56% year-over-year
- Next Earnings
- As of today, the next earnings release for EGRX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Eagle Pharmaceuticals, Inc. |
| Ticker | NASDAQ: EGRX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | eagleus.com |
| Employees | 134 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $0.97 | ||
| Price, 1D Change | 0.00% | |
| $13M | ||
| - | ||
| 1.07 | ||
| -5.17 | ||
| $316.61M | ||
| Revenue, 1Y Change | +84.56% | |
| $2.73 | ||
| EPS, 1Y Change | +512.71% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| $2.73 | ||
| EPS Estimate | - | N/A |
| EPS Est. Change | - | N/A |
| $316.61M | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| $0.97 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
No EPS data available
Revenue
No revenue data available
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -67.67% | ||
| -93.21% | ||
| -67.51% | ||
| -93.17% | ||
| +84.56% | ||
| +61.62% | ||
| +512.71% | ||
| +169.49% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $0.97 | ||
| $0.48 | ||
| $0.70 | ||
| $0.78 | ||
| $0.80 | ||
| $0.07 | ||
| -5.17 | ||
| $0.27 | ||
| 53.40 | ||
| 82.18% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $316.61M | ||
| $2.73 | ||
| $221.03M | ||
| 69.81% | ||
| $93.56M | ||
| -0.64% | ||
| $35.64M | ||
| 11.26% | ||
| $106.83M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.28 | ||
| 1.70 | ||
| 1.22 | ||
| - | ||
| 5 | ||
| 2.20 |
Valuations
| Metric | Value | Date |
|---|---|---|
| 1.07 | ||
| 0.05 | ||
| 0.05 | ||
| 1.09 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $233.56M | ||
| $55.32M | ||
| $406.16M | ||
| $188.75M | ||
| $172.60M | ||
| $111.09M | ||
| $65.51M | ||
| $7.78M | ||
| $18.99M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $280.97M | ||
| $127.47M | ||
| $95.58M | ||
| $106.63M | ||
| $13.27M | ||
| $0.00 | ||
| $25.79M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $50.70M | ||
| -$86.83M | ||
| -$6.21M | ||
| $178.00K | ||
| $50.52M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Piper Sandler | → | |
| Cantor Fitzgerald | ||
| Mizuho | → | |
| Piper Sandler | → | |
| PiperJaffray | → | |
| Cantor Fitzgerald | → | |
| Cantor Fitzgerald | ||
| Mizuho | → | |
| Mizuho | → | |
| Mizuho | → |
Analyst sentiment
Institutional ownership
Screeners with EGRX
FAQ
- What is the ticker symbol for Eagle Pharmaceuticals, Inc.?
- The ticker symbol for Eagle Pharmaceuticals, Inc. is NASDAQ:EGRX
- Does Eagle Pharmaceuticals, Inc. pay dividends?
- No, Eagle Pharmaceuticals, Inc. does not pay dividends
- What sector is Eagle Pharmaceuticals, Inc. in?
- Eagle Pharmaceuticals, Inc. is in the Healthcare sector
- What industry is Eagle Pharmaceuticals, Inc. in?
- Eagle Pharmaceuticals, Inc. is in the Specialty & Generic Drug Manufacturers industry
- What country is Eagle Pharmaceuticals, Inc. based in?
- Eagle Pharmaceuticals, Inc. is headquartered in United States
- When did Eagle Pharmaceuticals, Inc. go public?
- Eagle Pharmaceuticals, Inc. initial public offering (IPO) was on February 12, 2014
- Is Eagle Pharmaceuticals, Inc. in the S&P 500?
- No, Eagle Pharmaceuticals, Inc. is not included in the S&P 500 index
- Is Eagle Pharmaceuticals, Inc. in the NASDAQ 100?
- No, Eagle Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
- Is Eagle Pharmaceuticals, Inc. in the Dow Jones?
- No, Eagle Pharmaceuticals, Inc. is not included in the Dow Jones index
- When was Eagle Pharmaceuticals, Inc. last earnings report?
- Eagle Pharmaceuticals, Inc.'s most recent earnings report was on March 15, 2024
- When does Eagle Pharmaceuticals, Inc. report earnings?
- The date for Eagle Pharmaceuticals, Inc.'s next earnings report has not been announced yet
Data Sources & References
- EGRX Official Website www.eagleus.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/827871/000082787123000024/0000827871-23-000024-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/827871/000082787123000009/0000827871-23-000009-index.htm
- EGRX Profile on Yahoo Finance finance.yahoo.com/quote/EGRX
- EGRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/egrx